Skip to main content
Equibles

Jacob Johnson

Head of Investor Relations

Repligen Corp (RGEN)

Analyst

Stephens

Equibles does not estimate personal net worth.

Get an email with a short summary when Repligen Corp publishes a filing, an earnings call transcript or a press release.

Get RGEN alerts

About Jacob Johnson

Jacob Johnson is recorded as Head of Investor Relations at Repligen Corp (RGEN) and Analyst at Stephens. Jacob Johnson has spoken on 6 earnings calls and 1 other investor event across 1 company, most recently for Repligen Corp on July 28, 2026. Repligen Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Repligen Corp includes Olivier Loeillot (CEO and Board Member), Dr. Martin D. Madaus (Chairman and Board Member), Martin D. Madaus (Chairman) and 7 others.

Jacob Johnson on recent calls

“On this call, we will cover business highlights and financial performance for the three-month period ended June 30, 2026, and we'll provide financial guidance for the full year 2026.”
Head of Investor Relations, Earnings Release: Second Quarter of 2026 ·
“Earlier today, we announced a definitive agreement to acquire BioLife Solutions. In addition to the press release this morning, we have published a presentation which we will reference in our remarks.”
Head of Investor Relations, Repligen to Acquire BioLife Solutions Conference Call ·
“On this call, we will cover business highlights and financial performance for the three-month period ended March 31, 2026, and will provide financial guidance for the full year 2026.”
Head of Investor Relations, Repligen Corp Q1 FY2026 Earnings Call ·
“On this call, we will cover business highlights and financial performance for the three and 12-month periods ended December 31st, 2025, and we'll provide financial guidance for the full year 2026.”
Head of Investor Relations, Repligen Corp Q4 FY2025 Earnings Call ·
“On this call, we will cover business highlights and financial performance for the three-month period ended September 30, 2025, and will provide financial guidance for the full year 2025.”
Head of Investor Relations, Repligen Corp Q3 FY2025 Earnings Call ·

Affiliation history

  • Repligen Corp (RGEN)

    Head of Investor Relations

    Source not stated

    Current

  • Stephens

    Analyst

    Source not stated

    Current

Company network

Leadership on record at Repligen Corp

Recent activity